Please find the following complimentary resources below.
Dr. Nveed Chaudhary, Chief Scientific and Regulatory Officer
Dr. Nveed Chaudhary, Chief Scientific and Regulatory Officer
Dr. Nveed Chaudhary, Chief Scientific and Regulatory Officer
Dr. Nveed Chaudhary, Chief Scientific and Regulatory Officer
Paul Hardman, Head of Scientific Affairs
Dr. Nveed Chaudhary, Chief Regulatory Officer
Dr. Nveed Chaudhary, Chief Regulatory Officer
Chris Allen, Chief Scientific Officer
Chris Allen, Chief Scientific Officer
Chris Allen, Chief Scientific Officer
Yvonne Wilding, Director Product Safety and Compliance
Yvonne Wilding, Director Product Safety and Compliance
Yvonne Wilding, Director Product Safety and Compliance
Yvonne Wilding, Director Product Safety and Compliance
Yvonne Wilding, Director Product Safety and Compliance
Do you have the team in place ready for this stage? If not, now is the time to act. We can help.
If you are anticipating a letter and require supplementary data to support your PMTA, now is the time to act.
Series 1: Talking ENDS
Benjamin Green, Senior Project Manager, explains the Premarket Tobacco Product Application (PMTA) – open the door to the US market for ENDS companies.
Yvonne Wilding, Director Product Safety and Compliance, explains the differences in ENDS regulations.
Yvonne Wilding, Director Product Safety and Compliance, explains the similarities in ENDS regulations.
Learn more about computational prediction models in toxicology.
Dr. Emmanuel Minet, Principal Scientist, explains 3D Airways Cell Model for ENDS Aerosol exposure.
Learn more about how Broughton can help by clicking on the button below.
Series 2: Talking ENDS
Paul Hardman, Head of Scientific Affairs
Dr. Nveed Chaudhary, Chief Regulatory Officer.
Dr. Nveed Chaudhary, Chief Regulatory Officer.
Dr. Nveed Chaudhary, Chief Regulatory Officer.
Learn how our scientific experience and technical capabilities can help accelerate your pharmaceutical drug or device development project across different stages.
Subscribe to our regulatory digest for the latest industry updates.
Learn how we can help reduce costs and increase speed by enabling the right decision at key moments to avoid costly mistakes, delays, or reworks later in the project.
Learn more about how our Technical Due Diligence Fast Track service can help your business identify any weaknesses or gaps in the early stages of product development to better inform decision-making and investment choices.
Learn more about how our Technical Due Diligence Deep Dive service can offer an in-depth investigation of a product’s development status to ensure informed decision-making and better investment choices.
This infographic outlines the routes to a Pharmaceutical Marketing Authorization in the UK.
Broughton is a leading GMP analytical services provider. Learn more about what we offer.
Increase the value of your business with a successful PMTA with this guide for NGP businesses.
Learn the best statistical tools for QC Data Analysis and examples of how they can be applied in practice.
Get the overview for the Tobacco Products Directive and Tobacco-Related Products Regulations.
Download Broughton’s guide on the FDA final rule.
Understand the process for ENDS products.
See the key differences between TPD and Medicinal Product authorization for your ENDS products.
Learn more about Broughton’s ENDS dedicated extractables and leachables service.
Learn how to choose a laboratory that is the right fit.
Get helpful tips on areas to consider when conducting out of specification investigations.
Download a free infographic of our analytical services supporting drug development pathway.
Download our free test method transfer checklist today to help you with a compliant transfer process.
Download this case study to learn how Broughton helped a client reduce downtime in production.
At Broughton we have successfully transferred over 140 generic molecules and the list continues to expand. Download a copy today.
Selecting the right laboratory for quality control services is important to ensure you maintain customer satisfaction.
Broughton is a full analytical service provider with state-of-the-art facilities. View our full list of in-house techniques and capabilities.
Learn more about how we help companies of all sizes through the product lifecycle stages, from concept innovation, product realization, and regulatory submission to post marketing surveillance.
At Broughton we have spent the last 10 years working with UK, EU, and US regulators in relation to tobacco regulations being retrospectively applied to next generation nicotine products such as vapes and e-cigarettes.
At Broughton we can help summarise the regulatory pathways available for cannabinoid products and the legal requirements for each potential market route.
Download strategic insights to reignite PMTA confidence, reduce costs and protect timelines while continuing to innovate.
Learn more about our analytical services and laboratory testing.
Download our review of the degradation pathways of cannabinoids, the potential impact on medicinal and consumer products, and discussion of mitigation solutions.
Developing and commercializing new inhaled drug products requires huge energy and deep scientific understanding. Learn how Broughton can help.
Our team of in-house toxicologists reviews and evaluates toxicological data on a wide range of chemicals to produce independent expert opinions on risk assessment. Learn how we can help your business.
The evaluation of extractables and leachables is an essential component of the pharmaceutical development process.Learn how Broughton can help.
